IL17F and colorectal cancer: As shown in Fig 4A, the expression of β-defensin-1, β-defensin-3, and β-defensin-4 was markedly decreased in IL-17F-knockdown CMT93 cells, demonstrating that IL-17F can promote β-defensin expression in colorectal cancer cells.